Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -2.41% | 430.05 | 0.0% | $6120.58m | |
| BNTX | BioNTech SE | -3.62% | 359.18 | 0.0% | $1251.77m | |
| NVAX | Novavax, Inc. | 0.11% | 237.54 | 79.4% | $944.01m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 2.23% | 8.71 | 0.7% | $608.86m | |
| AMGN | Amgen, Inc. | 0.93% | 219.38 | 1.4% | $559.38m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.20% | 651.88 | 2.7% | $494.43m | |
| GILD | Gilead Sciences, Inc. | 0.39% | 71.61 | 1.0% | $434.34m | |
| ILMN | Illumina, Inc. | -0.65% | 447.01 | 3.5% | $405.38m | |
| TECH | Bio-Techne Corp. | 0.92% | 534.35 | 4.5% | $355.95m | |
| BIIB | Biogen, Inc. | 0.17% | 300.19 | 1.7% | $306.30m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.64% | 188.30 | 1.9% | $241.59m | |
| ISEE | IVERIC bio, Inc. | 1.59% | 16.62 | 0.0% | $194.78m | |
| BGNE | BeiGene Ltd. | 4.65% | 403.14 | 1.3% | $186.17m | |
| LIFE | aTyr Pharma, Inc. | 0.49% | 10.31 | 3.2% | $144.19m | |
| EXAS | EXACT Sciences Corp. | 5.22% | 108.15 | 18.1% | $135.69m |
Company Profile
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.